10-Q Filing

CARDINAL HEALTH INC CIK: 721371 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0000721371-23-000007`
Period End Date	20221231
Filing Date	20230202
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	cah-20221231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 92 Cash Flow Statement 68 Stockholders Equity 58 Comprehensive Income 28

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.65B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.72B	USD	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$11.42B	USD	Point-in-time
Trade receivables, net	`ReceivablesNetCurrent`	$10.56B	USD	Point-in-time
Inventories, net	`InventoryNet`	$17.26B	USD	Point-in-time
Inventories, net	`InventoryNet`	$15.64B	USD	Point-in-time
Common shares in treasury	`TreasuryStockShares`	68.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	54.00M	shares	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.02B	USD	Point-in-time
Prepaid expenses and other	`OtherAssetsCurrent`	$2.26B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$32.94B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$34.60B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.36B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.34B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$6.62B	USD	Point-in-time
Goodwill and other intangibles, net	`IntangibleAssetsNetIncludingGoodwill`	$7.63B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$927.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$953.00M	USD	Point-in-time
Total assets	`Assets`	$44.48B	USD	Point-in-time
Total assets	`Assets`	$43.88B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$27.13B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$30.08B	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$580.00M	USD	Point-in-time
Current portion of long-term obligations and other short-term borrowings	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$577.00M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.55B	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.84B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$30.55B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.21B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$4.68B	USD	Point-in-time
Long-term obligations, less current portion	`LongTermDebtAndCapitalLeaseObligations`	$4.74B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$9.30B	USD	Point-in-time
Deferred income taxes and other liabilities	`DeferredTaxAndOtherLiabilitiesNoncurrent`	$8.80B	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized500 thousand shares, Issuednone	`PreferredStockValue`	-	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2022 and June 30, 2022	`CommonStockValue`	$2.75B	USD	Point-in-time
Authorized755 million shares, Issued327 million shares at December 31, 2022 and June 30, 2022	`CommonStockValue`	$2.81B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-280.00M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-560.00M	USD	Point-in-time
Common shares in treasury, at cost: 68 million shares and 54 million shares at December 31, 2022 and June 30, 2022, respectively	`TreasuryStockValue`	$4.25B	USD	Point-in-time
Common shares in treasury, at cost: 68 million shares and 54 million shares at December 31, 2022 and June 30, 2022, respectively	`TreasuryStockValue`	$3.13B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-146.00M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-114.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$-709.00M	USD	Point-in-time
Total Cardinal Health, Inc. shareholders' equity	`StockholdersEquity`	$-2.21B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$3.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$1.00M	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.40B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.21B	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Total shareholders deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.78B	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$43.88B	USD	Point-in-time
Total liabilities and shareholders deficit	`LiabilitiesAndStockholdersEquity`	$44.48B	USD	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, authorized	`PreferredStockSharesAuthorized`	500,000.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred shares, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, authorized	`CommonStockSharesAuthorized`	755.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares, issued	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	68.00M	shares	Point-in-time
Common shares in treasury	`TreasuryStockShares`	54.00M	shares	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$51.47B	USD	1 Quarter
Revenue	`Revenues`	$45.46B	USD	1 Quarter
Revenue	`Revenues`	$101.07B	USD	2 Qtrs
Revenue	`Revenues`	$89.42B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$97.80B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$86.17B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$49.81B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$43.84B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.26B	USD	2 Qtrs
Gross margin	`GrossProfit`	$1.66B	USD	1 Quarter
Gross margin	`GrossProfit`	$1.62B	USD	1 Quarter
Gross margin	`GrossProfit`	$3.28B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.27B	USD	2 Qtrs
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.15B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.19B	USD	1 Quarter
Distribution, selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.39B	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$46.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$17.00M	USD	1 Quarter
Restructuring and employee severance	`RestructuringCharges`	$25.00M	USD	2 Qtrs
Restructuring and employee severance	`RestructuringCharges`	$7.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$79.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$71.00M	USD	1 Quarter
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$142.00M	USD	2 Qtrs
Amortization and other acquisition-related costs	`Amortizationandotheracquisitionrelatedcosts`	$158.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-863.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.29B	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.29B	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-710.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$207.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-52.00M	USD	2 Qtrs
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$-34.00M	USD	1 Quarter
Litigation (recoveries)/charges, net	`GainLossRelatedToLitigationSettlement`	$180.00M	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$-950.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$-119.00M	USD	1 Quarter
Operating earnings/(loss)	`OperatingIncomeLoss`	$-535.00M	USD	2 Qtrs
Operating earnings/(loss)	`OperatingIncomeLoss`	$18.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$5.00M	USD	2 Qtrs
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$7.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$13.00M	USD	1 Quarter
Other (income)/expense, net	`OtherNonoperatingIncomeExpense`	$17.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$37.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$25.00M	USD	1 Quarter
Interest expense, net	`InterestExpense`	$50.00M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$77.00M	USD	2 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	2 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	1 Quarter
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	2 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	2 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-973.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-137.00M	USD	1 Quarter
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-27.00M	USD	2 Qtrs
Earnings/(loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-604.00M	USD	2 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-925.00M	USD	2 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-1.02B	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-7.00M	USD	1 Quarter
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-8.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$321.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-130.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$49.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-19.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$49.00M	USD	1 Quarter
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$320.00M	USD	2 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-20.00M	USD	2 Qtrs
Net earnings/(loss) attributable to Cardinal Health, Inc.	`NetIncomeLoss`	$-130.00M	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.13	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.50	USD	1 Quarter
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.08	USD	2 Qtrs
Basic (in shares)	`IncomeLossFromContinuingOperationsPerBasicShare`	$0.17	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.08	USD	2 Qtrs
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.12	USD	2 Qtrs
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.50	USD	1 Quarter
Diluted (in shares)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$0.17	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	279.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	261.00M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	283.00M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	266.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	281.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	261.00M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	285.00M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	266.00M	shares	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.98	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.99	USD	2 Qtrs
Cash dividends declared per common share	`CommonStockDividendsPerShareDeclared`	$0.49	USD	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$321.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-130.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$49.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-19.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$341.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$332.00M	USD	2 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	1 Quarter
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	$1.00M	USD	2 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	2 Qtrs
(Gain)/loss on sale of equity interest in naviHealth	`GainLossOnSaleOfInvestments`	-	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-863.00M	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.29B	USD	1 Quarter
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-1.29B	USD	2 Qtrs
Impairments and (gain)/loss on disposal of assets, net	`GainLossOnSalesOfAssetsAndAssetImpairmentCharges`	$-710.00M	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-10.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$48.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$42.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$59.00M	USD	2 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$25.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$329.00M	USD	2 Qtrs
Increase in trade receivables	`IncreaseDecreaseInReceivables`	$919.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$361.00M	USD	2 Qtrs
Increase in inventories	`IncreaseDecreaseInInventories`	$1.64B	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.06B	USD	2 Qtrs
Increase in accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.95B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$1.84B	USD	2 Qtrs
Other accrued liabilities and operating items, net	`IncreaseDecreaseInOtherOperatingCapitalNet`	$1.06B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$549.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$620.00M	USD	2 Qtrs
Proceeds from divestitures, net of cash sold	`ProceedsFromDivestitureOfBusinesses`	-	USD	2 Qtrs
Proceeds from divestitures, net of cash sold	`ProceedsFromDivestitureOfBusinesses`	$938.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$141.00M	USD	2 Qtrs
Additions to property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$155.00M	USD	2 Qtrs
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Proceeds from disposal of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$2.00M	USD	2 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$1.00M	USD	2 Qtrs
Proceeds from investments	`Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments`	$22.00M	USD	2 Qtrs
Purchases of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$5.00M	USD	2 Qtrs
Purchases of investments	`Purchaseofavailableforsalesecuritiesandotherinvestments`	$4.00M	USD	2 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-157.00M	USD	2 Qtrs
Net cash provided by/(used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$815.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$13.00M	USD	2 Qtrs
Reduction of long-term obligations	`RepaymentsOfLongTermDebt`	$592.00M	USD	2 Qtrs
Net tax proceeds/(withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$9.00M	USD	2 Qtrs
Net tax proceeds/(withholdings) from share-based compensation	`Netproceedstaxwithholdingsfromsharebasedcompensation`	$-27.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$271.00M	USD	2 Qtrs
Dividends on common shares	`PaymentsOfDividendsCommonStock`	$289.00M	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.25B	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$800.00M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.71B	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.52B	USD	2 Qtrs
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-11.00M	USD	2 Qtrs
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.00M	USD	2 Qtrs
Cash and equivalents reclassified from/(to) assets held for sale	`CashReclassifiedToAssetHeldForSale`	$109.00M	USD	2 Qtrs
Cash and equivalents reclassified from/(to) assets held for sale	`CashReclassifiedToAssetHeldForSale`	-	USD	2 Qtrs
Net decrease in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.06B	USD	2 Qtrs
Net decrease in cash and equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-246.00M	USD	2 Qtrs
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.41B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.16B	USD	Point-in-time
Cash and equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.65B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.72B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.41B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.16B	USD	Point-in-time
Cash and equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.65B	USD	Point-in-time

Stockholders Equity 58 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.40B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.21B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.78B	USD	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	68.00M	shares	Point-in-time
Treasury, balance at beginning of period (in shares)	`TreasuryStockShares`	54.00M	shares	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$4.25B	USD	Point-in-time
Treasury, balance at beginning of period	`TreasuryStockValue`	$3.13B	USD	Point-in-time
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$321.00M	USD	2 Qtrs
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$-130.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$49.00M	USD	1 Quarter
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	`ProfitLoss`	$-19.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$49.00M	USD	1 Quarter
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$320.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$-20.00M	USD	2 Qtrs
Net Income (Loss) Attributable to Parent	`NetIncomeLoss`	$-130.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$30.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-51.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-32.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax	`OtherComprehensiveIncomeLossNetOfTax`	$-24.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-32.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-24.00M	USD	1 Quarter
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-51.00M	USD	2 Qtrs
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$30.00M	USD	1 Quarter
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodSharesShareBasedCompensation`	2.00M	shares	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$18.00M	USD	2 Qtrs
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$47.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$19.00M	USD	1 Quarter
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	`StockIssuedDuringPeriodValueShareBasedCompensation`	$58.00M	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$1.25B	USD	2 Qtrs
Purchase of treasury shares	`PaymentsForRepurchaseOfCommonStock`	$800.00M	USD	2 Qtrs
Dividends	`Dividends`	$139.00M	USD	1 Quarter
Dividends	`Dividends`	$280.00M	USD	2 Qtrs
Dividends	`Dividends`	$129.00M	USD	1 Quarter
Dividends	`Dividends`	$260.00M	USD	2 Qtrs
Other	`StockholdersEquityOther`	$1.00M	USD	1 Quarter
Other	`StockholdersEquityOther`	$-1.00M	USD	2 Qtrs
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period (in shares)	`CommonStockSharesIssued`	327.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.00B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.40B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.21B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-706.00M	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.78B	USD	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	68.00M	shares	Point-in-time
Treasury, balance at end of period (in shares)	`TreasuryStockShares`	54.00M	shares	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$4.25B	USD	Point-in-time
Treasury, balance at end of period	`TreasuryStockValue`	$3.13B	USD	Point-in-time
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$800.00M	USD	2 Qtrs
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$1.25B	USD	2 Qtrs
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$250.00M	USD	1 Quarter
Treasury Stock, Value, Acquired, Cost Method	`TreasuryStockValueAcquiredCostMethod`	$300.00M	USD	1 Quarter
Treasury shares acquired, average price per share (in usd per share)	`MinorityInterestDecreaseFromRedemptions`	$-2.00M	USD	2 Qtrs

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net earnings/(loss)	`ProfitLoss`	$321.00M	USD	2 Qtrs
Net earnings/(loss)	`ProfitLoss`	$-130.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$49.00M	USD	1 Quarter
Net earnings/(loss)	`ProfitLoss`	$-19.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-43.00M	USD	2 Qtrs
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$20.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-18.00M	USD	1 Quarter
Foreign currency translation adjustments and other	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-38.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-6.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$6.00M	USD	2 Qtrs
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$10.00M	USD	1 Quarter
Net unrealized gain/(loss) on derivative instruments, net of tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-8.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$30.00M	USD	1 Quarter
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-51.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-32.00M	USD	2 Qtrs
Total other comprehensive income/(loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-24.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$25.00M	USD	1 Quarter
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-51.00M	USD	2 Qtrs
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$270.00M	USD	2 Qtrs
Total comprehensive income/(loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-100.00M	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Less: Net earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-52.00M	USD	2 Qtrs
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$-100.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$25.00M	USD	1 Quarter
Total comprehensive income attributable to Cardinal Health, Inc.	`ComprehensiveIncomeNetOfTax`	$269.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.